Press Releases

Press Releases

Jazz Pharmaceuticals plc today announced that it will report its 2016 first quarter financial results on Tuesday, May 10, 2016, after the close of the financial markets.  Company management will host a live audio webcast immediately following the announcement at 4:30 p.m. EDT/9:30 p.m. IST to discuss first quarter 2016…

Press Releases

Navidea Biopharmaceuticals, Inc., announced today that Jed A. Latkin has been appointed interim Chief Operating Officer effective April 20, 2016. Jed has more than 20 years of experience in the financial industry supporting many investments in major markets including biotechnology and pharmaceuticals by providing executive direction and preserving operational control…

Press Releases

Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that Carolyn N. Krasner, M.D., of the Massachusetts General Hospital Cancer Center, will give an oral presentation on the Phase 1b results of an ongoing clinical trial of CRLX101 in combination with weekly paclitaxel in patients with relapsed…

Press Releases

Helsinn, the Swiss Group focused on building quality cancer care products and Purdue Pharma Canada today announce that they have signed an exclusive agreement for the distribution and licensing of Akynzeo®, the oral fixed combination of netupitant and palonosetron developed for the prevention of chemotherapy-induced nausea and vomiting (CINV). Under…

Press Releases

Astellas today announced key leadership appointments in its Ethics and Compliance and US Legal departments, taking effect April 25. Mark Wanda will join the Ethics and Compliance organization in the role of executive director, anti-bribery and anti-corruption, where he will oversee global anti-bribery and anti-corruption compliance programs for Astellas. Wanda…

Press Releases

Ascentage Pharma, a clinical-stage biopharmaceutical company focused on apoptosis-targeted oncology drug discovery and development, and UNITY Biotechnology, a San Francisco-based biopharmaceutical company focused on the development of medicines to improve healthspan, announced a worldwide collaboration to develop senolytic treatments for age-related disease. The Ascentage team has been working for over…

Press Releases

AbbVie and CytomX Therapeutics, Inc. today announced that they have entered into a collaboration to co-develop and co-commercialize Probody™ Drug Conjugates against CD71, also known as transferrin receptor 1 (TfR1). CD71 is highly expressed in a number of solid and hematologic cancers and has attractive molecular properties for efficient delivery…

Press Releases

PTC Therapeutics, Inc. announced that the Company will host a webcast conference call to report its first quarter financial results and provide an update on the company's business and outlook on Thursday, May 5, 2016 at 4:30 p.m. (ET) after the closing of the market. The call can be accessed…

Press Releases

Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight Time) on Thursday, April 28, 2016. To pre-register and access the live audio webcast, visit www.pfizer.com/proxy and click on the “Annual Meeting Webcast” button. Pre-registration begins…

Press Releases

Merrimack Pharmaceuticals, Inc. today announced that the company will host its First Quarter 2016 Investor Conference Call and webcast at 4:30 p.m., Eastern time, on Monday, May 2. The call will cover an update on Merrimack's progress as well as a summary of first quarter 2016 financials. A press release…